Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|6|547-566

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.6, 2009-07, pp. : 547-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Signaling Crosstalk Between Multiple Receptors for Investigation of Pathophysiology in Multifactorial Diseases - What is Clinically-Relevant Crosstalk?

By  

Current Medicinal Chemistry, Vol. 20, Iss. 9, 2013-03 ,pp. : 1091-1102

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphisms in dopamine receptors: what do they tell us?

By Hung Choy Wong A.   Buckle C.E.   Van Tol H.H.M.  

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 183-203

Elsevier

Access to resources Recommend Favorite

Biomarkers predicting treatment outcome in depression: what is clinically significant?

By Uher Rudolf   Tansey Katherine E   Malki Karim   Perlis Roy H  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 233-240

Future Medicine

Access to resources Recommend Favorite

Proteasome Inhibition: A Promising Strategy for Treating Cancer, but What About Neurotoxicity?

By  

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3025-3035

Bentham Science Publishers

Access to resources Recommend Favorite

What's In A Name?

By Elliott Barbara  

Addiction Research and Theory, Vol. 11, Iss. 5, 2003-01 ,pp. : 371-373

Informa Healthcare

Access to resources Recommend Favorite